ANAB - Financial Reports List - AnaptysBio, Inc. - IntrinsicAlpha

AnaptysBio, Inc. ANAB

Healthcare - Biotechnology - NASDAQ - US

$ 21.24

0.341 %

$ 651 M

Market Cap

-4.03

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	378.77%	48.39%	77.05%
Annual Report	FY	10-K	2024-12-31	432.03%	11.24%	30.08%
Quarterly Report	Q3	8-K	2024-09-30	804.67%	11.95%	39.69%
Quarterly Report	Q2	8-K	2024-06-30	217.08%	-17.10%	-0.44%
Quarterly Report	Q1	8-K	2024-03-31	422.49%	9.31%	4.95%
Quarterly Report	Q4	8-K	2023-12-31	32.27%	-59.81%	-62.23%
Annual Report	FY	10-K	2023-12-31	66.78%	-27.11%	-42.77%
Quarterly Report	Q3	8-K	2023-09-30	156.61%	0.17%	-27.33%
Quarterly Report	Q2	8-K	2023-06-30	184.54%	-6.80%	-44.40%
Quarterly Report	Q1	8-K	2023-03-31	41.65%	-18.85%	-39.85%

1